Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Icl Group Ltd (ICL) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Icl Group LtdTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Icl Group Ltd vs Health Care Select Sector SPDR Fund — how do they compare? Icl Group Ltd trades at $5.2 (market cap $6.65B), while Health Care Select Sector SPDR Fund trades at $158.25. The key difference: Icl Group Ltd pays a 3.77% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Icl Group Ltd nearer its low. Which is the better fit depends on your goals.

ICLXLV
Market Cap
$6.65B
Sector
Basic Materials
52-Week High
$7.03$164.48
52-Week Low
$4.80$129.01
Enterprise Value
$9.22B
Dividend Yield
3.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Icl Group Ltd

ICL trades at $5.00, down 0.99% over 24 hours, with a bearish technical signal. The company reported Q1 2026 earnings of $0.11 per share, beating estimates, and recently completed an $800 million senior notes offering. Revenue for 2025 was $7.15 billion with a net income margin of 3.15%, while valuation ratios show a P/E of 24.05 and P/S of 0.88. Analyst consensus is entirely hold-rated, reflecting cautious sentiment amid mixed financial trends.

The outlook for ICL is neutral with modest growth potential, supported by operational improvements and raised 2026 EBITDA guidance. Key risks include elevated raw material costs, foreign exchange headwinds, and competitive pressures in the specialty minerals sector. Investors should weigh stable cash flows against margin compression and debt levels from recent financing activities.

Health Care Select Sector SPDR Fund

XLV trades at $159.25, down 1.14% on the day, with technical indicators showing a bullish trend from moving averages but neutral oscillators. The healthcare ETF faces mixed sentiment with recent positive sector upgrades from State Street Investment Management but concerns about sector headwinds during earnings season. Support levels cluster around $158-160, while resistance sits at $163-165.

The healthcare sector offers defensive characteristics amid market volatility, with XLV providing diversified exposure. Key risks include patent cliffs for major holdings and election-year policy uncertainty. Analyst sentiment is cautiously optimistic given the sector's stability and innovation pipeline, though relative performance versus technology remains a concern.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Icl Group Ltd

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.

Read more on ICL

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV